Page last updated: 2024-12-10

toxiferine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Toxiferine: A curare alkaloid that is a very potent competitive nicotinic antagonist at the neuromuscular junction. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
CuraregenusPlant extracts from several species, including genera STRYCHNOS and Chondodendron, which contain TETRAHYDROISOQUINOLINES that produce PARALYSIS of skeletal muscle. These extracts are toxic and must be used with the administration of artificial respiration.[MeSH]LoganiaceaeA plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida. They have leaflike appendages at the base of the leafstalks, have terminal flower clusters. Petals have four or five overlapping lobes and the fruit is a capsule containing winged or wingless seeds.[MeSH]

Cross-References

ID SourceID
PubMed CID5281411
CHEMBL ID1184078
CHEBI ID9644
SCHEMBL ID3132546
MeSH IDM0021723

Synonyms (12)

Synonym
C09246
toxiferine
toxiferine i, 2,2',16,16'-tetradehydro-16,16',17,17'-tetrahydro-
302-30-7
9m7d9k3oji ,
unii-9m7d9k3oji
CHEMBL1184078
CHEBI:9644 ,
SCHEMBL3132546
Q392418
(2e)-2-[(1s,9z,11s,13s,14s,17s,25z,27s,30s,33s,35s,36s,38e)-38-(2-hydroxyethylidene)-14,30-dimethyl-8,24-diaza-14,30-diazoniaundecacyclo[25.5.2.211,14.11,26.110,17.02,7.013,17.018,23.030,33.08,35.024,36]octatriaconta-2,4,6,9,18,20,22,25-octaen-28-ylidene]
DTXSID30897243

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" However, during onset of and offset of effect, the pharmacodynamic parameters ECp50 and ECp95 for the limb muscle were lower than in the diaphragm."( Alcuronium pharmacodynamics in dogs: effect-concentration relationships in the diaphragmatic and limb muscles.
Borton, C; Brown, KF; Shanks, CA; Walker, JS, 1987
)
0.27
"The pharmacokinetic behaviour of alcuronium was studied in three patients undergoing resection of an aortic aneurysm, and in another two patients undergoing total hip replacement (group I)."( Pharmacokinetics of alcuronium in elderly patients undergoing total hip replacement or aortic reconstructive surgery.
Bourne, DW; Ho, PC; Holloway, AM; Stephens, ID; Triggs, EJ, 1984
)
0.27
"The pharmacokinetic behaviour of alcuronium is described for nineteen patients undergoing anaesthesia for elective surgery."( Clinical pharmacokinetics of alcuronium chloride in man.
Shanks, CA; Triggs, EJ; Walker, J, 1980
)
0.26

Dosage Studied

ExcerptRelevanceReference
" the pretreatment with Alcuronium can enhance intentionally the duration of action of Atracurium and spare total dosage of muscle relaxants at the same time."( [Atracurium--increased duration of its effect following alcuronium].
Janda, A; Mühlsteiger, B; Schwarz, S, 1990
)
0.28
" In the first study, cumulative dose-response curves were constructed in four groups of 10 patients anaesthetized with one of the inhalation agents and nitrous oxide, or with fentanyl and droperidol (control)."( Potentiation of the neuromuscular blockade produced by alcuronium with halothane, enflurane and isoflurane.
Hunter, JM; Keens, SJ; Snowdon, SL; Utting, JE, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkaloidAny of the naturally occurring, basic nitrogen compounds (mostly heterocyclic) occurring mostly in the plant kingdom, but also found in bacteria, fungi, and animals. By extension, certain neutral compounds biogenetically related to basic alkaloids are also classed as alkaloids. Amino acids, peptides, proteins, nucleotides, nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. Compounds in which the nitrogen is exocyclic (dopamine, mescaline, serotonin, etc.) are usually classed as amines rather than alkaloids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (256)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990247 (96.48)18.7374
1990's5 (1.95)18.2507
2000's1 (0.39)29.6817
2010's3 (1.17)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.75 (24.57)
Research Supply Index5.74 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials35 (12.77%)5.53%
Reviews7 (2.55%)6.00%
Case Studies16 (5.84%)4.05%
Observational0 (0.00%)0.25%
Other216 (78.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]